SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-058598
Filing Date
2012-10-31
Accepted
2012-10-31 13:52:22
Documents
8
Period of Report
2012-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v326949_8k.htm 8-K 27684
2 EXHIBIT 10.1 v326949_ex10-1.htm EX-10.1 193927
3 EXHIBIT 10.2 v326949_ex10-2.htm EX-10.2 151278
4 EXHIBIT 10.3 v326949_ex10-3.htm EX-10.3 10108
5 EXHIBIT 10.4 v326949_ex10-4.htm EX-10.4 49816
6 EXHIBIT 99.1 v326949_ex99-1.htm EX-99.1 10929
7 GRAPHIC tlogo.jpg GRAPHIC 19838
8 GRAPHIC tlogo1.jpg GRAPHIC 15466
  Complete submission text file 0001144204-12-058598.txt   494176
Mailing Address 3985 RESEARCH PARK DRIVE, SUITE 200 ANN ARBOR MI 48108
Business Address 3985 RESEARCH PARK DRIVE, SUITE 200 ANN ARBOR MI 48108 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 121170342
SIC: 2834 Pharmaceutical Preparations